COCHLEAR LIMITED Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Cochlear Limited |
ABN 96 002 618 073 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Christopher Michael Smith |
Date of last notice | 7 November 2016 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Not applicable |
Date of change | Change 1: 11 August 2017 Change 2: 17 August 2017 |
No. of securities held prior to change |
|
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director's Interest NoticeClass |
|
Number acquired | Change 1: 2,027 Shares Change 2: 2,998 Shares |
Number disposed | Nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Change 1: 2,027 STI Performance Rights at Nil exercise price Change 2: 2,998 LTI Performance Rights at Nil exercise price |
No. of securities held after change |
|
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Change 1 and Change 2: Mr Smith acquired a total of 5,025 Shares through the exercise of 2,998 LTI Performance Rights, and 2,027 STI Performance Rights under the Cochlear Executive Incentive Plan (CEIP). Each Performance Right entitles Mr Smith to subscribe for, be allocated or receive the transfer of, one fully paid ordinary share in Cochlear Limited. |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Detail of contract |
Nature of interest |
Name of registered holder (if issued securities) |
Date of change |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
Interest acquired |
Interest disposed |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
Interest after change |
Part 3 - +Closed period
Appendix 3Y Change of Director's Interest NoticeWere the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | Not applicable |
If prior written clearance was provided, on what date was this provided? | Not applicable |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Cochlear Ltd. published this content on 18 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 August 2017 04:06:01 UTC.
Original documenthttp://coh.live.irmau.com/irm/PDF/1437_0/Appendix3YChrisSmith
Public permalinkhttp://www.publicnow.com/view/361F6AAAF4BC63B7852B3672ED83FE6768D8CA1A
